Article
Identification of an Immune-Related Prognostic Risk Model in Glioblastoma
17 Jun 2022
Abstract excerpt
Background: Glioblastoma (GBM) is the most common and malignant type of brain tumor. A large number of studies have shown that the immunotherapy of tumors is effective, but the immunotherapy effect of GBM is not poor. Thus, further research on the immune-related hub genes of GBM is extremely important. Methods: The GBM highly correlated gene clusters were screened out by differential expression, mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
